DE69816057D1 - Antibakterielle substituierte 7-acylamino-3-(methylhydrazono)methyl-cephalosporine und zwischenprodukte - Google Patents

Antibakterielle substituierte 7-acylamino-3-(methylhydrazono)methyl-cephalosporine und zwischenprodukte

Info

Publication number
DE69816057D1
DE69816057D1 DE69816057T DE69816057T DE69816057D1 DE 69816057 D1 DE69816057 D1 DE 69816057D1 DE 69816057 T DE69816057 T DE 69816057T DE 69816057 T DE69816057 T DE 69816057T DE 69816057 D1 DE69816057 D1 DE 69816057D1
Authority
DE
Germany
Prior art keywords
methylhydrazono
cephalosporine
acylamino
methyl
intermediate products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69816057T
Other languages
English (en)
Other versions
DE69816057T2 (de
Inventor
Gerd Ascher
Josef Wieser
Michael Schranz
Johannes Ludescher
Johannes Hildebrandt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nabriva Therapeutics AG
Original Assignee
Biochemie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT54797A external-priority patent/AT405180B/de
Application filed by Biochemie GmbH filed Critical Biochemie GmbH
Publication of DE69816057D1 publication Critical patent/DE69816057D1/de
Application granted granted Critical
Publication of DE69816057T2 publication Critical patent/DE69816057T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69816057T 1997-04-01 1998-04-01 Antibakterielle substituierte 7-acylamino-3-(methylhydrazono)methyl-cephalosporine und zwischenprodukte Expired - Lifetime DE69816057T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AT54897 1997-04-01
AT54697 1997-04-01
AT54797A AT405180B (de) 1997-04-01 1997-04-01 Neue derivate von substituierten 3-cephem-4-carbonsäurederivaten und verfahren zu deren herstellung
AT54697 1997-04-01
AT54797 1997-04-01
AT54897 1997-04-01
PCT/EP1998/001890 WO1998043981A1 (en) 1997-04-01 1998-04-01 Antibacterial substituted 7-acylamino-3-(methylhydrazono)methyl -cephalosporins and intermediates

Publications (2)

Publication Number Publication Date
DE69816057D1 true DE69816057D1 (de) 2003-08-07
DE69816057T2 DE69816057T2 (de) 2004-04-15

Family

ID=27146440

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816057T Expired - Lifetime DE69816057T2 (de) 1997-04-01 1998-04-01 Antibakterielle substituierte 7-acylamino-3-(methylhydrazono)methyl-cephalosporine und zwischenprodukte

Country Status (21)

Country Link
EP (2) EP0973780B1 (de)
JP (2) JP3363157B2 (de)
KR (2) KR100481143B1 (de)
CN (1) CN1117095C (de)
AU (1) AU734897B2 (de)
BR (1) BR9807913A (de)
CA (1) CA2284501C (de)
DE (1) DE69816057T2 (de)
DK (1) DK0973780T3 (de)
ES (1) ES2203955T3 (de)
HK (1) HK1026692A1 (de)
ID (1) ID22441A (de)
IL (1) IL131849A (de)
NO (1) NO325687B1 (de)
NZ (1) NZ337732A (de)
PL (1) PL200130B1 (de)
PT (1) PT973780E (de)
RU (1) RU2201933C2 (de)
SK (1) SK133099A3 (de)
TR (1) TR199902387T2 (de)
WO (1) WO1998043981A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT406772B (de) * 1998-03-23 2000-08-25 Biochemie Gmbh Antibakterielle 7-acylamino-3-iminomethyl- cephalosporine und verfahren zu deren herstellung
US6504025B2 (en) * 2000-05-24 2003-01-07 Basilea Pharmaceutica Ag Process for the preparation of vinyl-pyrrolidinone cephalosporin derivatives
AT413282B (de) * 2002-02-01 2006-01-15 Sandoz Ag Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
CA3147354A1 (en) 2019-09-06 2021-03-11 Rosemarie Riedl Siderophore cephalosporin conjugates and uses thereof
CN111187281B (zh) * 2020-02-11 2023-03-14 广西科技大学 含胍基的头孢菌素衍生物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU190639B (en) * 1983-12-12 1986-09-29 Gyogyszerkutato Intezet Kv,Hu Process for production of new aminoguanidin derivatives
FI851934L (fi) * 1984-05-30 1985-12-01 Ici Plc Kefalosporinderivat.
EP0824535B1 (de) * 1995-05-11 2003-02-26 Biochemie Gesellschaft M.B.H. Antibakterielle cephalosporinverbindungen

Also Published As

Publication number Publication date
NO994719D0 (no) 1999-09-28
RU2201933C2 (ru) 2003-04-10
BR9807913A (pt) 2000-02-22
CN1251591A (zh) 2000-04-26
IL131849A0 (en) 2001-03-19
NO994719L (no) 1999-09-28
ES2203955T3 (es) 2004-04-16
KR20000076288A (ko) 2000-12-26
NO325687B1 (no) 2008-07-07
PL200130B1 (pl) 2008-12-31
JP3363157B2 (ja) 2003-01-08
JP2002316992A (ja) 2002-10-31
CN1117095C (zh) 2003-08-06
PL336004A1 (en) 2000-06-05
AU7521398A (en) 1998-10-22
PT973780E (pt) 2003-11-28
ID22441A (id) 1999-10-14
JP2000514832A (ja) 2000-11-07
NZ337732A (en) 2001-09-28
AU734897B2 (en) 2001-06-28
EP1300408A1 (de) 2003-04-09
DE69816057T2 (de) 2004-04-15
HK1026692A1 (en) 2000-12-22
SK133099A3 (en) 2001-03-12
KR20040000380A (ko) 2004-01-03
IL131849A (en) 2004-05-12
DK0973780T3 (da) 2003-10-27
CA2284501A1 (en) 1998-10-08
WO1998043981A1 (en) 1998-10-08
KR100481143B1 (ko) 2005-04-08
EP0973780B1 (de) 2003-07-02
TR199902387T2 (xx) 2000-01-21
CA2284501C (en) 2007-07-17
EP0973780A1 (de) 2000-01-26

Similar Documents

Publication Publication Date Title
NO20000125D0 (no) Tiadiazolyl- og oksadiazolylfenyloksazolidinon- antibakterielle midler
DE69815668D1 (de) Bauprodukte
DE69828963D1 (de) Wirstoffabgabe und gentherapiesystem
DE69509464T2 (de) Antimikrobielles Mittel
ID19853A (id) Barang absorban
NO985643D0 (no) Antimikrobielle blandinger
DE69908353D1 (de) Pigmentprodukte
DE59804367D1 (de) Sterilisierbehälter
DE69510254D1 (de) Antimikrobielles Mittel
NO993353D0 (no) Tverr- og aksialarmerte pultruderingsprodukter
DE59812502D1 (de) Chitosanmikrosphären
DE959898T1 (de) Laktoferrin varianten und verwendungen davon
DE69700949T2 (de) Pflegemittel
DE69916694D1 (de) 2-Hydroxy-5-methyl-hexan-3-on und 3-hydroxy-5-methyl-hexan-2-on
DE69723818D1 (de) Polyesteranhydride und ihre zwischenprodukte
DE19983493T1 (de) Sauerteigprodukt
ID19697A (id) Pembuatan barang-barang ekstrusi
DE69816057D1 (de) Antibakterielle substituierte 7-acylamino-3-(methylhydrazono)methyl-cephalosporine und zwischenprodukte
DE69842206D1 (de) Echounterdrücker und echounterdrückungsverfahren
DE69512261T2 (de) Diebstahlsicherer profilsatz und profilstreifen hierfür
DE29706027U1 (de) Sicherheitsprodukt
ATE244250T1 (de) Antibakterielle substituierte 7-acylamino-3- (methylhydrazono)methyl-cephalosporine und zwischenprodukte
DE29710820U1 (de) Teigware
DE69706088T2 (de) Markierte Teigprodukten
DE29614677U1 (de) Autopflegemittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANDOZ AG, BASEL, CH

8327 Change in the person/name/address of the patent owner

Owner name: NABRIVA THERAPEUTICS FORSCHUNG GMBH, WIEN, AT

8327 Change in the person/name/address of the patent owner

Owner name: NABRIVA THERAPEUTICS AG, WIEN, AT

8330 Complete renunciation